Exogenous Interleukin-12 Protects against Lethal Infection with Coxsackievirus B4
Open Access
- 1 August 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (15) , 8272-8279
Abstract
Infections with the group B coxsackieviruses either can be asymptomatic or can lead to debilitating chronic diseases. To elucidate the mechanism by which these viruses cause chronic disease, we developed a mouse model of chronic pancreatitis by using a virulent variant of coxsackievirus B4, CVB4-V. Infection with CVB4-V results in an early, severe pancreatitis, which can lead to mortality or progress to chronic pancreatitis. Chronic pancreatitis, in this model, is due to immunopathological mechanisms. We investigated whether interleukin-12 (IL-12) could modulate the outcome of CVB4-V infection. Eighty-five percent of the infected mice treated with 500 ng of IL-12 survived, whereas all untreated mice succumbed. To understand the mechanism underlying the beneficial effect of IL-12, we investigated the role of gamma interferon (IFN-γ). Three lines of evidence suggest that the protective effect of IL-12 is due to IFN-γ. First, administration of IL-12 increased the production of endogenous IFN-γ in CVB4-V-infected mice. Both NK and NKT cells were identified as the source of IFN-γ. Second, IFN-γ knockout mice treated with IL-12 succumbed to infection with CVB4-V. Third, wild-type mice treated with IFN-γ survived infection with CVB4-V. Due to the antiviral effects of IFN-γ, we examined whether IL-12 treatment affected viral replication. Administration of IL-12 did not decrease viral replication in the pancreas, but it did prevent extensive tissue damage and the subsequent development of chronic pancreatitis. The data suggest that IL-12 treatment during CVB4-V infection is able to suppress the immunopathological mechanisms that lead to chronic disease.Keywords
This publication has 37 references indexed in Scilit:
- IL-12 and Viral InfectionsCytokine & Growth Factor Reviews, 1998
- DIFFERENTIAL PRODUCTION OF INTERLEUKIN-6 IN THE BRAIN AND SPLEEN OF MICE TREATED WITH LIPOPOLYSACCHARIDE IN THE PRESENCE AND ABSENCE OF LEADJournal of Toxicology and Environmental Health, Part A, 1998
- Coxsackieviruses and diabetesBioEssays, 1997
- The Pathogenesis of Postinfectious MyocarditisClinical Immunology and Immunopathology, 1996
- Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.Journal of Experimental Medicine, 1995
- IL 12 in acute viral infectious diseaseResearch in Immunology, 1995
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infectionJournal of General Virology, 1992
- Severity of disease induced by a pancreatropic Coxsackie B4 virus correlates with the H-2K q locus of the major histocompatibility complexVirus Research, 1989
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.Journal of Experimental Medicine, 1989